Roumen Balabanov to Combined Modality Therapy
This is a "connection" page, showing publications Roumen Balabanov has written about Combined Modality Therapy.
Connection Strength
0.036
-
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial. JAMA. 2019 01 15; 321(2):165-174.
Score: 0.036